Most Read Articles
Rachel Soon, 26 Jun 2018

MIMS Pharmacist presents an overview of phosphatidylcholine's physiological role, as well as contemporary research on its pharmacology and effects.

17 Mar 2018
Nonvitamin K antagonist oral anticoagulants (NOAC)-associated intracerebral haemorrhage (ICH) and vitamin K antagonists-ICH appear to have similar ICH volume, haematoma expansion, functional outcome and mortality, results of a recent meta-analysis have shown.
31 May 2017
New drug applications approved by US FDA as of 16 - 31 May 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
09 Dec 2017
Intravenous (IV) iron is less toxic and more effective compared to oral iron, making it a potential frontline therapy for neonatal iron deficiency anaemia, suggests a recent study.

Oral antibiotics up risk of kidney stones

Tristan Manalac
19 May 2018

Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for  with recent antibiotic exposure and those who were exposed at a younger age.

Exposure to sulfas (odds ratio [OR], 2.33; 95 percent CI, 2.19–2.48; p<0.001), cephalosporins (OR, 1.88; 1.75–2.01; p<0.001) and fluoroquinolones (OR, 1.67; 1.54–1.81; p<0.001) increased the risk of being diagnosed with nephrolithiasis 3–12 months after prescription. [J Am Soc Nephrol 2018;doi:10.1681/ASN.2017111213]

The same was true for nitrofurantoins (OR, 1.7; 1.55–1.88; p<0.001) and broad-spectrum penicillins (OR, 1.27; 1.18–1.36; p<0.001). Receiving treatment for Helicobacter pylori 3–12 months prior also increased the risk of nephrolithiasis diagnosis (OR, 1.79; 1.21–2.65; p=0.003).

Age significantly affected the relationship between oral antibiotic use and nephrolithiasis development (p<0.001).  Those who were exposed at younger ages had much higher odds of developing nephrolithiasis than those who took the antibiotics at an older age.

Recent exposure was likewise a significant interaction factor for all oral antibiotic classes examined. Those who were exposed to sulfas (OR, 2.63; 2.42–2.85; p<0.001), cephalosporins (OR, 2.26; 2.06–2.48; p<0.001), fluoroquinolones (OR, 1.98; 1.77–2.22; p<0.001), nitrofurantoins (OR, 2.16; 1.9–2.46; p<0.001) and broad-spectrum penicillins (OR, 1.44; 1.26–1.61; p<0.001) within 3–6 months of the index date showed the highest risk.

Risk from exposure 6–12 months prior to diagnosis was lower, but remained significant: sulfas (OR, 2.16; 1.92–2.22; p<0.001), cephalosporins (OR, 1.7; 1.57–1.84; p<0.001), fluoroquinolones (OR, 1.59; 1.44–1.75; p<0.001), nitrofurantoins (OR, 1.69; 1.51–1.9; p<0.001) and broad-spectrum penicillins (OR, 1.21; 1.11–1.32; p<0.001).

The effect of all five oral antibiotic classes on the risk of nephrolithiasis development remained significant even when exposure was 3–5 years prior to diagnosis.

The present findings indicate that oral antibiotics likely contribute to the increased formation of calcium-based calculi, as most of the nephrolithiasis cases in industrialized countries involve stones of such composition, said researchers.

“One potential mechanism is that antibiotics change composition of the intestinal microbiome and consequently alter macronutrient metabolism,” they explained, adding that antibiotics may also promote the domination of multidrug resistant bacteria in the urinary microbiome, leading to stone formation. [Nephrol Dial Transplant 2012;27:4125-4130; Cell 2014;158:705-721]

“Future studies should examine the underlying microbial biomolecular mechanisms and change in intestinal metabolic products caused by different antibiotics,” they said.

Researchers performed a population-based, nested case-control study including 25,981 nephrolithiasis patients and 259,797 controls (34.9 percent female for both groups). Information on oral antibiotic prescriptions during the 3–12-month primary exposure period was retrieved from The Health Improvement Network database.

In the context of the recent rise in the prescription and administration of antibiotics, “[o]ur findings support the hypothesis that antibiotics may be contributing to the increasing prevalence and earlier age at onset of nephrolithiasis,” said researchers.

“Given that children receive more antibiotics than any other age group, and 3 percent of antibiotics prescribed during ambulatory care visits are inappropriate, these findings provide another reason to reduce inappropriate outpatient antibiotic use,” they added. [JAMA 2002;287:3133-3135; N Engl J Med 2013;368:1461-1462; JAMA 2016;315:1864-1873]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 26 Jun 2018

MIMS Pharmacist presents an overview of phosphatidylcholine's physiological role, as well as contemporary research on its pharmacology and effects.

17 Mar 2018
Nonvitamin K antagonist oral anticoagulants (NOAC)-associated intracerebral haemorrhage (ICH) and vitamin K antagonists-ICH appear to have similar ICH volume, haematoma expansion, functional outcome and mortality, results of a recent meta-analysis have shown.
31 May 2017
New drug applications approved by US FDA as of 16 - 31 May 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
09 Dec 2017
Intravenous (IV) iron is less toxic and more effective compared to oral iron, making it a potential frontline therapy for neonatal iron deficiency anaemia, suggests a recent study.